Newcastle upon Tyne
NE1 7RU
United Kingdom
SARS-CoV-2, immune-mediated inflammatory diseases, inflammatory bowel disease, thiopurine, azathioprine, anti-TNF therapy, infliximab, vedolizumab, immunosuppressant, vaccine, ChAdOx1 nCoV-19, BNT162b2, mRNA1273, breakthrough infection, Omicron, BA.4/5